[vc_tta_section i_icon_fontawesome="fa fa-folder-open-o" title="Abstract"... Leer más →
Target-specific oral anticoagulants (TSOACs) dabigatran, rivaroxaban and apixaban are approved for the prevention and treatment of... Leer más →
Background Four new oral anticoagulants compare favourably with warfarin for... Leer más →
Background New oral anticoagulants represent an alternative to standard... Leer más →